Lipid metabolizing proteins may elevate susceptibility to
dementia leading to differences in genetic makeup. PCR-restriction fragment length polymorphism technique is used for genotyping of
LRPAP1 intron 5 insertion/deletion. Suppression of receptor-binding domain of LRP LDLR is due to overexpression of LRPAP (the protein product of LRPAP gene). LRP gives protection across LDL by LRPAP and its downregulation may be subjected for an elevation of LDL and Ab-related neuronal toxicity as LRP supports in binding of ligand and internalization of LRP ligands like apo-E-enriched LDL cholesterol and Ab protein. Results being consistent with earlier study where the authors have endowed deletion
allele frequency clearly high in late-onset Alzheimer’s disease patients on comparison with non-demented aged controls. Influencing
TGF-β activity, chaperone of LRP1 is encoded by LRPAP1.Notably salient deficiency of LRP1 and upregulation of
TGF-β in affected individuals cells, the known data being consistent on the importance of TGF-β in remodeling for the sclera of myopia and the increased frequency in individuals for myopia having
Marfan syndrome which has characteristics of upregulated TGF-β signaling. Analysizing the absence of the normal protein was done with immunoblot for affected individuals having LRPAP1 mutations revealing the mutations in
LRPAP1 probability of loss-of-function mutations. A model suggested by a study wherein LRPAP1 leading to deficiency of
LRP1 which was responsible to perturbation of TGF-β regulation and might cause abnormal ECM remodeling in the eye development. Therefore, individuals having myopia responding to therapeutic strategy initiated before ECM remodeling could be considered as an approach for individuals with LRPAP1 related myopia. == References ==